COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
暂无分享,去创建一个
Alexander R. Pico | Benjamin M. Gyori | John A. Bachman | Sara Sadat Aghamiri | Lincoln D. Stein | Takahiro G. Yamada | Thawfeek M. Varusai | Emily E. Ackerman | Egon L. Wilighagen | C. Sander | J. Beckmann | C. Auffray | H. Kitano | S. Ballereau | M. Gillespie | P. D’Eustachio | B. Jassal | L. Matthews | A. Bauch | R. Haw | O. Wolkenhauer | S. Soliman | J. Hasenauer | K. Hanspers | E. Barillot | R. Balling | Guanming Wu | E. Demir | H. Hermjakob | C. Goble | J. Dopazo | Reinhard Schneider | J. Saez-Rodriguez | T. Korcsmáros | A. Yuryev | M. Acencio | F. Sacco | A. Mazein | B. De Meulder | E. Glaab | V. Satagopam | Anita de Waard | C. Evelo | F. Schreiber | L. Calzone | T. Freeman | A. Funahashi | A. Luna | J. Shoemaker | Jeremy D. Zucker | O. Babur | M. Kutmon | T. Helikar | A. Ruepp | D. Börnigen | P. Porras | L. Licata | A. Valencia | M. Vazquez | I. Kuperstein | Anders Riutta | D. Slenter | V. Shamovsky | Laurent Heirendt | Barbara Brauner | G. Fobo | G. Frishman | Corinna Montrone | D. Turei | D. Módos | R. Phair | D. Maier | A. Naldi | M. Peña-Chilet | Kinza Rian | Alberto Valdeolivas | N. Hiroi | Yusuke Hiki | K. Rothfels | Cristoffer Sevilla | S. Coort | F. Ehrhart | M. Ostaszewski | Leonard Schmiester | A. Montagud | B. L. Puniya | Vera Ortseifen | A. Treveil | M. Orlic-Milacic | Marvin Martens | M. Iannuccelli | F. Augé | L. Eijssen | Matti Hoch | L. C. Monraz Gómez | P. Gawron | V. Grouès | Z. Bocskei | Aurélien Dugourd | J. Ravel | A. Niarakis | J. Teuton | J. Scheel | M. Olbei | Kristie L. Oxford | D. Rex | Alina Renz | R. Fraser | Muying Wang | F. Messina | R. Overall | S. Owen | Gokce Yagmur Summak | Xiaoming Hu | Andreas Dräger | Tobias Czauderna | Aurelio Orta-Resendiz | Miguel Ponce de Leon | Julia Somers | Ebru Kocakaya | S. Marchesi | M. Esteban-Medina | Vidisha Singh | Vincent Noël | A. Pico | M. Conti | Nhung Pham | Martin Golebiewski | Ewa Smula | Shailendra Kumar Gupta | Hanna Borlinghaus | Muhammad Naveez | L. Fergusson | Marius Rameil | Vanessa Nakonecnij | Carlos Vega | A. Nesterova | Jakob Vanhoefer | Andrea Senff Ribeiro | Ralf Stephan | M. Vázquez | S. Aghamiri | Akira Funahashi | Daniela Börnigen | Goar Frishman | Augustin Luna | Laurence Calzone | B. de Meulder | Arnau Montagud | Valentin Grouès | Xiaoming Hu
[1] Timothy L. Tickle,et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.
[2] L. Steinmetz,et al. Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut , 2021, Molecular systems biology.
[3] Fabian J Theis,et al. Integrated intra‐ and intercellular signaling knowledge for multicellular omics analysis , 2021, Molecular systems biology.
[4] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[5] Aurélien Naldi,et al. Setting the basis of best practices and standards for curation and annotation of logical models in biology - highlights of the [BC]2 2019 CoLoMoTo/SysMod Workshop , 2020, Briefings Bioinform..
[6] Y. Bi,et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation , 2020, Developmental Cell.
[7] Andreas Dräger,et al. FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2 , 2020, Bioinformatics.
[8] Joseph H. Lubin,et al. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic , 2020, bioRxiv.
[9] Alexander R. Pico,et al. Pathway information extracted from 25 years of pathway figures , 2020, Genome Biology.
[10] G. Altan-Bonnet,et al. β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway , 2020, Cell.
[11] L. Steinmetz,et al. Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut , 2020, bioRxiv.
[12] Peng Zhou,et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation , 2020, Signal Transduction and Targeted Therapy.
[13] D. Zipeto,et al. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19 , 2020, Frontiers in Immunology.
[14] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[15] Ai-Ming Yu,et al. The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) , 2020, International journal of molecular sciences.
[16] P. Shi,et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age , 2020, PLoS biology.
[17] Stephan Moser,et al. Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System , 2020, Frontiers in Immunology.
[18] E. Shin,et al. The type I interferon response in COVID-19: implications for treatment , 2020, Nature Reviews Immunology.
[19] J. Eckel,et al. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? , 2020, Frontiers in Pharmacology.
[20] Yong Wang,et al. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 , 2020, Protein & Cell.
[21] Tamás Korcsmáros,et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis , 2020, bioRxiv.
[22] Hiroaki Kitano,et al. SBML Level 3: an extensible format for the exchange and reuse of biological models , 2020, Molecular systems biology.
[23] R. Serra,et al. COVID-19 and the Kidney: From Epidemiology to Clinical Practice , 2020, Journal of clinical medicine.
[24] Andrew Emili,et al. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors , 2020, bioRxiv.
[25] Raphael Gottardo,et al. Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories , 2020, bioRxiv.
[26] Peihui Wang,et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling , 2020, bioRxiv.
[27] Eric Song,et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.
[28] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[29] S. Nisole,et al. Interplay between SARS-CoV-2 and the type I interferon response , 2020, PLoS pathogens.
[30] Daniel J Klionsky,et al. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19 , 2020, Cells.
[31] Karlheinz Peter,et al. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications , 2020, Circulation research.
[32] A. T. Te Velde,et al. Severe COVID-19: NLRP3 Inflammasome Dysregulated , 2020, Frontiers in Immunology.
[33] Catherine E. Costello,et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 , 2020, bioRxiv.
[34] Andrew R. Leach,et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.
[35] Toshiaki Iba,et al. The unique characteristics of COVID-19 coagulopathy , 2020, Critical Care.
[36] Javad Alizadeh,et al. Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management? , 2020, European Journal of Pharmacology.
[37] Ting Yang,et al. Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein , 2020, Biochemical and Biophysical Research Communications.
[38] Alimuddin Zumla,et al. COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection , 2020, Journal of Translational Medicine.
[39] Ugur Dogrusoz,et al. Systems biology graphical notation markup language (SBGNML) version 0.3 , 2020, J. Integr. Bioinform..
[40] Akiko Iwasaki,et al. Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19 , 2020, Cell Host & Microbe.
[41] J. Berthelot,et al. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta , 2020, EBioMedicine.
[42] Shan Su,et al. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2 , 2020, Signal Transduction and Targeted Therapy.
[43] Thomas Becker,et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 , 2020, Science.
[44] Anna Niarakis,et al. Automated inference of Boolean models from molecular interaction maps using CaSQ , 2020, Bioinform..
[45] T. Hussain. Faculty Opinions recommendation of Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. , 2020 .
[46] Malik Peiris,et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures , 2020, The Lancet Respiratory Medicine.
[47] Hiroaki Kitano,et al. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms , 2020, Scientific Data.
[48] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[49] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[50] M. Hoffmann,et al. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.
[51] Slobodan Paessler,et al. Antiviral activities of type I interferons to SARS-CoV-2 infection , 2020, Antiviral Research.
[52] Aurelien Dugourd,et al. Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses , 2020, bioRxiv.
[53] Oren Etzioni,et al. CORD-19: The Covid-19 Open Research Dataset , 2020, NLPCOVID19.
[54] David Berlin,et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.
[55] Marta R. Hidalgo,et al. Mechanistic modeling of the SARS-CoV-2 disease map , 2020, BioData Mining.
[56] D. Gommers,et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.
[57] Dong Yang,et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] Yafei Wang,et al. Iterative community-driven development of a SARS-CoV-2 tissue simulator , 2020, bioRxiv.
[59] Roland Eils,et al. SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells , 2020, The EMBO journal.
[60] Jaipaul Singh,et al. The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role? , 2020, Medical archives.
[61] Robert J. Mason,et al. Pathogenesis of COVID-19 from a cell biologic perspective , 2020, European Respiratory Journal.
[62] Yuzhang Wu,et al. The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes , 2020, medRxiv.
[63] Han Zhang,et al. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis , 2020, Journal of the American College of Radiology.
[64] Fabian J Theis,et al. SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.
[65] Han-Ming Shen,et al. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 , 2020, International journal of biological sciences.
[66] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[67] M. Letko,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[68] Lu Lu,et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein , 2020, Cellular & Molecular Immunology.
[69] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[70] Andrei Zinovyev,et al. cd2sbgnml: bidirectional conversion between CellDesigner and SBGN formats , 2020, Bioinform..
[71] M. Pellegrini,et al. The IMEx coronavirus interactome: an evolving map of Coronaviridae–host molecular interactions , 2020, Database : the journal of biological databases and curation.
[72] C. Auffray,et al. Informing epidemic (research) responses in a timely fashion by knowledge management - a Zika virus use case. , 2020, Biology Open.
[73] Livia Perfetto,et al. SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update , 2019, Nucleic Acids Res..
[74] Chris Sander,et al. Pathway Commons 2019 Update: integration, analysis and exploration of pathway data , 2019, Nucleic Acids Res..
[75] Marek Ostaszewski,et al. Closing the gap between formats for storing layout information in systems biology , 2019, Briefings Bioinform..
[76] Qin Ning,et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .
[77] Mingyi Zhao,et al. New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases , 2019, Oxidative medicine and cellular longevity.
[78] Vincent Lotteau,et al. Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition. , 2019, European journal of medicinal chemistry.
[79] T. Fung,et al. Human Coronavirus: Host-Pathogen Interaction. , 2019, Annual review of microbiology.
[80] Julio Saez-Rodriguez,et al. Footprint-based functional analysis of multiomic data , 2019, Current opinion in systems biology.
[81] David K. Finlay,et al. Competition for nutrients and its role in controlling immune responses , 2019, Nature Communications.
[82] Alimuddin Zumla,et al. Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies , 2019, Front. Microbiol..
[83] Piotr Gawron,et al. MINERVA API and plugins: opening molecular network analysis and visualization to the community , 2019, Bioinform..
[84] A. Ploss,et al. Decoding type I and III interferon signalling during viral infection , 2019, Nature Microbiology.
[85] Panuwat Trairatphisan,et al. From expression footprints to causal pathways: contextualizing large signaling networks with CARNIVAL , 2019, npj Systems Biology and Applications.
[86] M. Heller,et al. Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling , 2018, eLife.
[87] Henning Hermjakob,et al. Complex Portal 2018: extended content and enhanced visualization tools for macromolecular complexes , 2018, Nucleic Acids Res..
[88] Emmanuel Barillot,et al. PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling , 2018, bioRxiv.
[89] Priyanka Garg,et al. Involving community in genes and pathway curation , 2019, Database.
[90] Dhruv Chauhan,et al. BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages. , 2018, Cell reports.
[91] Pedro T. Monteiro,et al. Logical Modeling and Analysis of Cellular Regulatory Networks With GINsim 3.0 , 2018, Front. Physiol..
[92] J. Sáez-Rodríguez,et al. Benchmark and integration of resources for the estimation of human transcription factor activities , 2018, bioRxiv.
[93] Feng He,et al. Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms , 2018, npj Systems Biology and Applications.
[94] Anthony Rowe,et al. A computational framework for complex disease stratification from multiple large-scale datasets , 2018, BMC Systems Biology.
[95] Aurélien Naldi,et al. The CoLoMoTo Interactive Notebook: Accessible and Reproducible Computational Analyses for Qualitative Biological Networks , 2018, bioRxiv.
[96] Younho Choi,et al. Autophagy during viral infection — a double-edged sword , 2018, Nature Reviews Microbiology.
[97] Judith A. Smith. Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity , 2018, Front. Immunol..
[98] Sven Sahle,et al. SBML Level 3 package: Render, Version 1, Release 1 , 2018, J. Integr. Bioinform..
[99] E. Sklan,et al. TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing , 2018, Nature Communications.
[100] T. Fung,et al. Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3 , 2017, Virology.
[101] Ryan Miller,et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research , 2017, Nucleic Acids Res..
[102] John Kunze,et al. Uniform resolution of compact identifiers for biomedical data , 2017, Scientific Data.
[103] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[104] Zhengfan Jiang,et al. NEMO–IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS–STING Pathway , 2017, The Journal of Immunology.
[105] Randy Heiland,et al. PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems , 2017, bioRxiv.
[106] Aurélien Naldi,et al. MaBoSS 2.0: an environment for stochastic Boolean modeling , 2017, Bioinform..
[107] F. Arnaud,et al. From core referencing to data re-use: two French national initiatives to reinforce paleodata stewardship (National Cyber Core Repository and LTER France Retro-Observatory) , 2017 .
[108] Benjamin M. Gyori,et al. From word models to executable models of signaling networks using automated assembly , 2017, bioRxiv.
[109] Bernd Rinn,et al. FAIRDOMHub: a repository and collaboration environment for sharing systems biology research , 2016, Nucleic Acids Res..
[110] Dexter Pratt,et al. NDEx: A Community Resource for Sharing and Publishing of Biological Networks. , 2017, Methods in molecular biology.
[111] Julio Saez-Rodriguez,et al. OmniPath: guidelines and gateway for literature-curated signaling pathway resources , 2016, Nature Methods.
[112] Francisco Salavert,et al. High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes , 2016, bioRxiv.
[113] S. Makino,et al. Viral and Cellular mRNA Translation in Coronavirus-Infected Cells , 2016, Advances in Virus Research.
[114] Alexander G. Fletcher,et al. Comparing individual-based approaches to modelling the self-organization of multicellular tissues , 2016, bioRxiv.
[115] Piotr Gawron,et al. MINERVA—a platform for visualization and curation of molecular interaction networks , 2016, npj Systems Biology and Applications.
[116] Mariano J. Alvarez,et al. Network-based inference of protein activity helps functionalize the genetic landscape of cancer , 2016, Nature Genetics.
[117] A. Califano,et al. Network-based inference of protein activity helps functionalize the genetic landscape of cancer , 2016, Nature Genetics.
[118] Marek Ostaszewski,et al. Integration and Visualization of Translational Medicine Data for Better Understanding of Human Diseases , 2016, Big Data.
[119] Francisco Salavert,et al. Actionable pathways: interactive discovery of therapeutic targets using signaling pathway models , 2016, Nucleic Acids Res..
[120] Chris T. A. Evelo,et al. Reactome from a WikiPathways Perspective , 2016, PLoS Comput. Biol..
[121] Lei Wan,et al. SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6 , 2016, International journal of molecular sciences.
[122] Chuan Qin,et al. Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways , 2015, The Journal of infectious diseases.
[123] Zhiyong Lu,et al. GNormPlus: An Integrative Approach for Tagging Genes, Gene Families, and Protein Domains , 2015, BioMed research international.
[124] Nuno Nunes,et al. PathVisio 3: An Extendable Pathway Analysis Toolbox , 2015, PLoS Comput. Biol..
[125] Frank T. Bergmann,et al. The Systems Biology Markup Language (SBML) Level 3 Package: Layout, Version 1 Core , 2015, J. Integr. Bioinform..
[126] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[127] J. Kassis,et al. Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity , 2014, PloS one.
[128] Zhongbin Chen,et al. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex , 2014, Protein & Cell.
[129] Samik Ghosh,et al. Modeling and simulation using CellDesigner. , 2014, Methods in molecular biology.
[130] N. Grandvaux,et al. STAT2 and IRF9: Beyond ISGF3. , 2013, JAK-STAT.
[131] C. Rice,et al. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage , 2013, The EMBO journal.
[132] Steffen Klamt,et al. SBML qualitative models: a model representation format and infrastructure to foster interactions between qualitative modelling formalisms and tools , 2013, BMC Systems Biology.
[133] B. Neuman,et al. Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles , 2013, mBio.
[134] A. Alcamí,et al. Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection. , 2013, Cell host & microbe.
[135] Yukio Imamura,et al. Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases , 2013, Mediators of inflammation.
[136] Neema Jamshidi,et al. Updating and curating metabolic pathways of TB. , 2013, Tuberculosis.
[137] Yukihito Ishizaka,et al. Monitoring of S Protein Maturation in the Endoplasmic Reticulum by Calnexin Is Important for the Infectivity of Severe Acute Respiratory Syndrome Coronavirus , 2012, Journal of Virology.
[138] Alex Madrahimov,et al. The Cell Collective: Toward an open and collaborative approach to systems biology , 2012, BMC Systems Biology.
[139] Johannes Goll,et al. Protein interaction data curation: the International Molecular Exchange (IMEx) consortium , 2012, Nature Methods.
[140] Nicolas Le Novère,et al. Identifiers.org and MIRIAM Registry: community resources to provide persistent identification , 2011, Nucleic Acids Res..
[141] Michel Dumontier,et al. Controlled vocabularies and semantics in systems biology , 2011, Molecular systems biology.
[142] Marta L. DeDiego,et al. Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis , 2011, PLoS pathogens.
[143] S. Simmons,et al. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells , 2011, Free Radical Biology and Medicine.
[144] Gary D Bader,et al. BioPAX – A community standard for pathway data sharing , 2010, Nature Biotechnology.
[145] Falk Schreiber,et al. Editing, validating and translating of SBGN maps , 2010, Bioinform..
[146] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[147] Felix Jonas,et al. Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode , 2010, Protein & Cell.
[148] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[149] Chris T. A. Evelo,et al. The BridgeDb framework: standardized access to gene, protein and metabolite identifier mapping services , 2010, BMC Bioinformatics.
[150] Sarala M. Wimalaratne,et al. The Systems Biology Graphical Notation , 2009, Nature Biotechnology.
[151] H. Schätzl,et al. Modulation of Host Cell Death by SARS Coronavirus Proteins , 2009, Molecular Biology of the SARS-Coronavirus.
[152] T. Mogensen. Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses , 2009, Clinical Microbiology Reviews.
[153] David A. Stein,et al. Severe Acute Respiratory Syndrome Coronavirus Triggers Apoptosis via Protein Kinase R but Is Resistant to Its Antiviral Activity , 2008, Journal of Virology.
[154] T. Sasazuki,et al. Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry , 2008, Proceedings of the National Academy of Sciences.
[155] Zhongbin Chen,et al. Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus , 2007, Journal of Biological Chemistry.
[156] Ralph S. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane , 2007, Journal of Virology.
[157] Mo Liu,et al. Spike protein of SARS‐CoV stimulates cyclooxygenase‐2 expression via both calcium‐dependent and calcium‐independent protein kinase C pathways , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[158] Kouji Matsushima,et al. Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation , 2006, FEBS Letters.
[159] Michael Karin,et al. Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.
[160] K. Timani,et al. Activation of NF‐κB by the Full‐length Nucleocapsid Protein of the SARS Coronavirus , 2005, Acta biochimica et biophysica Sinica.
[161] Anton Yuryev,et al. Extracting human protein interactions from MEDLINE using a full-sentence parser , 2004, Bioinform..
[162] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[163] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[164] Hartmut Bossel,et al. Modeling and simulation , 1994 .